CIK 0001404281
- Non-accelerated filer
- Smaller reporting company
Eledon Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELDN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 949-238-8090
- Business address
- 19800 MACARTHUR BLVD., SUITE 250, IRVINE, CA, 92612
- Former names
- Eledon Pharmaceuticals, Inc., Novus Therapeutics, Inc., Tokai Pharmaceuticals Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-03-19 | FLESHER GREGORY J. Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2019-09-26 | FLESHER GREGORY J. Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2019-05-21 | FLESHER GREGORY J. Chief Executive Officer | Sale | −2,937 | $1.91 | $6K | 156,918 |
| 2019-05-20 | FLESHER GREGORY J. Chief Executive Officer | Sale | −11,701 | $1.96 | $23K | 159,855 |
| 2019-03-14 | FLESHER GREGORY J. Chief Executive Officer | Grant or award | +25,000 | 171,556 | ||
| 2019-03-14 | FLESHER GREGORY J. Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 | ||
| 2018-03-13 | FLESHER GREGORY J. Chief Executive Officer | Grant or award | +30,700 | 146,556 | ||
| 2018-03-13 | FLESHER GREGORY J. Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +56,500 | 56,500 | ||
| 2017-05-24 | FLESHER GREGORY J. Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2017-05-10 | FLESHER GREGORY J. Chief Executive Officer | Purchase | +58,959 | $9.99 | $589K | 115,856 |
Page 1 of 1 · 10 trades